$GILD Company News Industry titan UnitedHealth misses

New Post Public Reply Private Reply Replies (0) Message Board

May 29, 2014 at 10:42 AM

$GILD Company News

Industry titan UnitedHealth misses boom in sector 38 min ago - Russ Britt
Gilead says its drug gives hepatitis C patients more cost-effective cure 5:06 p.m. April 30, 2014 - blogs.marketwatch.com
Why a diverse ETF portfolio is right for these times 6:29 a.m. April 30, 2014 - John Prestbo
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
What Obamacare problems? Aetna results not showing any ill effects 12:34 p.m. April 24, 2014 - blogs.marketwatch.com
U.S. stocks tumble; S&P 500 ends 6-day run 4:46 p.m. April 23, 2014 - Anora Mahmudova
Apple, Facebook stuck in red ahead of earnings 3:02 p.m. April 23, 2014 - Saumya Vaishampayan
U.S. stock futures pause after six-session win streak 8:57 a.m. April 23, 2014 - Sara Sjolin
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Apple, Facebook, Boeing are stocks to watch 5:30 a.m. April 23, 2014 - Sue Chang
Gilead shares climb; AT&T, Amgen shares fall 5:55 p.m. April 22, 2014 - Myra P. Saefong
Gilead scores big on earnings with new drug, but investors getting wary 5:46 p.m. April 22, 2014 - blogs.marketwatch.com
Gilead earnings buoyed by Hepatitis-C drug 5:04 p.m. April 22, 2014 - Anna Prior
Gilead Sciences shares up 4.5% in after-hours trade 4:35 p.m. April 22, 2014 - Myra P. Saefong
Gilead beats expectations; Sovaldi sales hit $2.3 bln 4:22 p.m. April 22, 2014 - Claudia Assis
Gilead: Hep C drug Sovaldi sells $2.27 billion 4:17 p.m. April 22, 2014 - Claudia Assis
Gilead Sciences Q1 non GAAP EPS $1.48 vs. 48c 4:15 p.m. April 22, 2014 - Claudia Assis
Should doctors care what treatments cost? 4:14 p.m. April 22, 2014 - blogs.marketwatch.com
Gilead shares to resume trade at 4:30 Eastern 4:09 p.m. April 22, 2014 - Laura Mandaro
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com

Orexigen (OREX) in Focus: Stock Moves 6.1% Higher - Tale of the Tape 55 min ago - Zacks.com
Xenoport, Inc. (XNPT) Soars: Stock Up 5.9% - Tale of the Tape 9:39 a.m. Today - Zacks.com
KaloBios Pharmaceuticals (KBIO) Worth Watching: Stock Up 5.3% - Tale of the Tape 9:25 a.m. Today - Zacks.com
GTX Inc. (GTXI) Soars: Stock Up 9.7% - Tale of the Tape 8:51 a.m. Today - Zacks.com
VIVUS Inc. (VVUS) in Focus: Stock Up 6% - Tale of the Tape 8:44 a.m. Today - Zacks.com
InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Amid Carnage In Group, These Biotechs Stand Out 4:51 p.m. May 28, 2014 - Investors Business Daily
Incyte Joins Forces with Bristol-Myers - Analyst Blog 4:30 p.m. May 28, 2014 - Zacks.com
Valeant Selling Product Rights to Nestle - Analyst Blog 4:20 p.m. May 28, 2014 - Zacks.com
AbbVie Up on HCV Filing in Canada - Analyst Blog 3:04 p.m. May 28, 2014 - Zacks.com
Nasdap Stocks With the Most Short Interest 11:16 a.m. May 28, 2014 - 247WallSt.com
Stock Market News for May 28, 2014 - Market News 10:06 a.m. May 28, 2014 - Zacks.com
Verastem (VSTM) in Focus: Stock Adds 14% in Session - Tale of the Tape 9:39 a.m. May 28, 2014 - Zacks.com
Dyax Corp. (DYAX) Soars: Stock Rises 27.4% - Tale of the Tape 8:51 a.m. May 28, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS) in Focus: Stock Rises 9.21% - Tale of the Tape 8:44 a.m. May 28, 2014 - Zacks.com
Equity Pullback in the Cards but Outlook Will Brighten Later This Year 8:33 a.m. May 28, 2014 - TheStreet.com
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. May 28, 2014 - Seeking Alpha
Amgen's Vectibix Label Expanded - Analyst Blog 6:30 p.m. May 27, 2014 - Zacks.com
CHMP Negative on Novartis' RLX030 - Analyst Blog 6:15 p.m. May 27, 2014 - Zacks.com
CHMP Positive on Roche's Gazyvaro - Analyst Blog 5:30 p.m. May 27, 2014 - Zacks.com

Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
AHF: ‘Negligent Corporate Welfare’ Pushes Gilead to Top of S&P 500 5:40 p.m. May 22, 2014 - BusinessWire - BZX
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape 12:38 p.m. May 22, 2014 - PR Newswire - PRF
Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults 5:00 p.m. May 20, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 2014 UBS Healthcare Conference on Tuesday, May 20 5:00 p.m. May 19, 2014 - BusinessWire - BZX
Critical Alerts For Goldman Sachs, Noodles & Company, Starbucks, Gilead Sciences, and Time Warner Cable Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference on Wednesday, May 14 5:00 p.m. May 13, 2014 - BusinessWire - BZX
Gilead Announces Phase 1 Data for Investigational Therapy, GS-6615, in Patients with Long QT-3 Syndrome 4:31 p.m. May 9, 2014 - BusinessWire - BZX
Cancer Diagnostics Partnering Terms and Agreements 5:41 p.m. May 7, 2014 - PR Newswire - PRF
Gilead Announces $5 Billion Share Repurchase Program 5:17 p.m. May 7, 2014 - BusinessWire - BZX
Medivir: a Supplemental New Drug Application Has Been Submitted to the U.S. FDA for Simeprevir in Combination with Sofosbuvir 8:06 a.m. May 7, 2014 - BusinessWire - BZX
Biotech Stocks Review -- Research on Retrophin, Merrimack, Gilead Sciences, and Rexahn Pharma 12:37 p.m. May 6, 2014 - PR Newswire - PRF
BetterInvesting Magazine Releases July Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. May 2, 2014 - PR Newswire - PRF
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors 9:00 a.m. April 30, 2014 - PR Newswire - PRF
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Critical Alerts For Comcast, Gilead Sciences, Ciena, Adobe Systems, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. April 29, 2014 - PR Newswire - PRF
Federal Circuit Rules for Axinn Client Natco Pharma Ltd. in Tamiflu Patent Appeal 1:50 p.m. April 25, 2014 - BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Gilead Sciences Announces First Quarter 2014 Financial Results 4:03 p.m. April 22, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gate's Strong Q3: Sales Growth & Rising Margins

Solid Performance Boosts Confidence Gates Industrial came out swinging with their third-quarter results for 2026, showing some financial prowess that would make even the skeptics raise an eyebrow. Net sales climbed to a hefty $903.6 million, advancing 5.6% from the same time last year. It's not just smoke—core sales jumped 5.5%, signaling they're doing a bit more than...

Florida's Natural, Johnsonville Settle Bet Over Juice

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Viatris Bids for Pacira: Strategic Healthcare Move

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Z Squared Eyes 150 MW Expansion at Arkansas Site

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

HIMS Faces Class Action Over Alleged Privacy Violations

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Tetragon's September Factsheet Offers Unique Insights

A Peek into Tetragon's Financial Playbook Every once in a while, you come across a player in the finance world that operates by its own rules. Tetragon Financial Group is one of those mavericks, and they've dropped their September 2026 Monthly Factsheet. Now here's a company that knows how to keep you guessing while serving up some real financial meat. Investment Strategy...

ANTHBOT N8 Wins Honors: A New Era in Lawn Care?

Rising Above the Grass Well, here's a twist: ANTHBOT's latest robot mower, the N8, caught the eyes of TIME magazine and snagged a spot on their Best Inventions of 2026 list. A lawnmower? You bet. And not just any lawnmower—this one's doing a whole song and dance with its 4-in-1 approach that'll make any garden-owning homeowner's life simpler. Kudos to them for shaking...

Willis Automotive Changes Hands: A Deep Dive

By Evelyn Baker Updated Oct 29, 2026 Category News Views 117

A Historic Shift in Iowa's Auto Dealership Landscape Shifts in ownership can be like the changing of the guard, and we've got a significant one unfolding in Iowa. Rich Willis, a stalwart of the dealership game, is passing the baton—not to just anyone, but to a duo with serious heritage in the industry: Jason Willis and Collin Sewell. The transaction sees Willis...

Winter Travel Booms: Top Destinations Unveiled for 2026

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Circus Circus Vegas Offers Halloween Deals for Families

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...